Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma

This study is currently recruiting participants.
Information provided by Amgen

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Sarcoma
			Soft Tissue Sarcoma
2		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Connective and Soft Tissue
3		Interventions listed in this trial
			AMG 655
			Placebo
4		Additional drug interventions recognized in this trial
			Doxorubicin
5		More general drug interventions related to this trial
			Antibiotics, Antineoplastic
			Antineoplastic Agents
			Pharmacologic Actions
			Therapeutic Uses
6		Sponsors listed in this trial
			Amgen